Data from Investigational Device Exemption (IDE) study in Roux-en-Y gastric bypass procedures used to support application for De Novo classification Second IDE approved for U.S. clinical trial for ...

A J&J executive shares the objectives behind the design of the company's Ottava surgical robot and what will help it stand ...

Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification.

(RTTNews) - Johnson & Johnson (JNJ), Wednesday announced the submission of an application to the U.S. Food and Drug Administration, seeking De Novo classification for OTTAVA Robotic Surgical System, a ...

The sources of economic moats are varied, but few are as powerful as monopoly. Companies that dominate their niche markets ...

Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.